Intermountain, Stanford Partner on Clinical Genomics Initiative | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Intermountain, Stanford Partner on Clinical Genomics Initiative

April 22, 2016
by Heather Landi
| Reprints
Click To View Gallery

Intermountain Healthcare and the Stanford Genome Technology Center (SGTC) have established a new collaborative research program with the aim of producing scientific advances in precision health and medicine.

The joint research team consists of members of Intermountain’s Precision Genomics Core Laboratory, based in St. George, Utah, and SGTC based in Palo Alto, California. The team of researchers and clinicians are working to identify novel biomarkers using an advanced array of technologies developed at SGTC, according to an Intermountain Healthcare announcement.

The focus of the research will be on solving clinical issues for patients using cutting-edge technologies that enable delivery of precision health, while also providing scientific expertise and research support for Intermountain Healthcare’s Precision Genomics.

"We are pleased Intermountain Precision Genomics is collaborating in the area of genome technology with Stanford Medicine, one of the nation's finest academic research centers," Terri Kane, vice president of Intermountain Healthcare's Southwest Region said in a statement. "This research partnership has the potential for a direct and very positive impact on our ability to extend the lives and improve the quality of life for patients with advanced cancer among other health issues."

According to the announcement, one of the key objectives in the collaboration is to determine the clinical benefits associated with applying molecular analysis to patient care.  “The research agreement allows for the joint development of innovative technologies to enable clinical research focused on precision medicine and directly address critical questions in precision health.  Likewise, this will provide Stanford with an invaluable opportunity to conduct clinical population-based studies that will accelerate adoption of precision health,” Lincoln Nadauld, M.D., Ph.D., executive director of precision medicine and precision genomics at Intermountain Healthcare, said in a statement.

Hanlee Ji, M.D., the senior associate director of SGTC and an associate professor at the Stanford School of Medicine in the Division of Oncology said the research program will address critical research questions in the development of precision health. “Conducting our studies in collaboration with Intermountain Healthcare will enable our joint team to address more ambitious clinical research questions on a much broader scale,” he said.

The collaboration is part of broader partnership between Intermountain and Stanford to support projects in research, patient care and medical education.

Intermountain Precision Genomics is a service of Intermountain Healthcare, which offers genetic sequencing of solid tumors. This in-depth sequencing identifies individual mutations within a person’s cancer cells to identify specific DNA targets for personalized drugs.

SGTC is a research center at the Stanford University School of Medicine that integrates personnel and expertise from the Stanford departments of Medicine, Genetics, Biochemistry and Electrical Engineering. SGTC’s mission is to develop innovative biomedical technologies that reduce the costs of health care.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Dignity Health, UCSF Health Partner to Improve the Digital Patient Experience

Dignity Health and UCSF Health are collaborating to develop a digital engagement platform that officials believe will provide information and access to patients when and where they need it as they navigate primary and preventive care, as well as more acute or specialty care.

Report: Digital Health VC Funding Surges to Record $4.9 Billion in 2018

Global venture capital funding for digital health companies in the first half of 2018 was 22 percent higher year-over-year (YoY) with a record $4.9 billion raised in 383 deals compared to the $4 billion in 359 deals in the same time period last year, according to Mercom Capital Group’s latest report.

ONC Roundup: Senior Leadership Changes Spark Questions

The Office of the National Coordinator for Health IT (ONC) has continued to experience changes within its upper leadership, leading some folks to again ponder what the health IT agency’s role will be moving forward.

Media Report: Walmart Hires Former Humana Executive to Run Health Unit

Reigniting speculation that Walmart and insurer Humana are exploring ways to forge a closer partnership, Walmart Inc. has hired a Humana veteran to run its health care business, according to a report from Bloomberg.

Value-Based Care Shift Has Halted, Study Finds

A new study of 451 physicians and health plan executives suggests that progress toward value-based care has stalled. In fact, it may have even taken a step backward over the past year, the research revealed.

Study: EHRs Tied with Lower Hospital Mortality, But Only After Systems Have Matured

Over the past decade, there has been significant national investment in electronic health record (EHR) systems at U.S. hospitals, which was expected to result in improved quality and efficiency of care. However, evidence linking EHR adoption to better care is mixed, according to medical researchers.